Last reviewed · How we verify
NCT03947931: REXs_UC
Russian Extremely Severe Ulcerative Colitis Study
trial in Ulcerative Colitis in 71 participants. Completed in 20 June 2022.
20 June 2021
Quick facts
| Lead sponsor | State Scientific Centre of Coloproctology, Russian Federation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 71 |
| Start date | 20 June 2019 |
| Primary completion | 20 June 2021 |
| Estimated completion | 20 June 2022 |
| Sites | 1 location across Russia |
Conditions studied
- Ulcerative Colitis — all drugs for Ulcerative Colitis →
- Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →
Sponsor
State Scientific Centre of Coloproctology, Russian Federation — full company profile →
Who can join
18 and older, any sex, with Ulcerative Colitis or Inflammatory Bowel Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is prove the need to selection of a extremely severe ulcerative colitis, to identify predictors of colectomy, which will reduce the optimal time for surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03947931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ulcerative Colitis
Currently open trials in the same condition.
- NCT07185009 — A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Acti · Phase 3 · recruiting
- NCT07265570 — Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) · Phase 2 · recruiting
- NCT07223424 — Patient Preference for Subcutaneous vs. Intravenous Immune Therapy · Phase 2 · recruiting
- NCT06405087 — A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD · Phase 3 · recruiting
- NCT07184996 — An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ · Phase 3 · recruiting
Other State Scientific Centre of Coloproctology, Russian Federation trials
Trials by the same sponsor.
- NCT07268261 — Combined Method of Surgical Treatment of Anal Fissure · NA · recruiting
- NCT05598164 — Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure · NA · unknown
- NCT05495776 — Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer · recruiting
- NCT05117697 — Surgical Treatment of a Chronic Anal Fissure · NA · unknown
- NCT05228054 — Treatment of Hemorrhoid With 1940nm Laser Procedure · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03947931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by State Scientific Centre of Coloproctology, Russian Federation
- Last refreshed: 25 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03947931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing